[go: up one dir, main page]

DK1427728T3 - 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner - Google Patents

6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner

Info

Publication number
DK1427728T3
DK1427728T3 DK02763693T DK02763693T DK1427728T3 DK 1427728 T3 DK1427728 T3 DK 1427728T3 DK 02763693 T DK02763693 T DK 02763693T DK 02763693 T DK02763693 T DK 02763693T DK 1427728 T3 DK1427728 T3 DK 1427728T3
Authority
DK
Denmark
Prior art keywords
pyrazolo
pyrazol
dihydro
inflammatory cytokines
controlling inflammatory
Prior art date
Application number
DK02763693T
Other languages
English (en)
Inventor
Michael Phillip Clark
Matthew John Laufersweiler
Jane Far-Jine Djung
Michael George Natchus
Biswanath De
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK1427728T3 publication Critical patent/DK1427728T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK02763693T 2001-09-20 2002-09-20 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner DK1427728T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32362501P 2001-09-20 2001-09-20
PCT/US2002/030135 WO2003024971A1 (en) 2001-09-20 2002-09-20 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Publications (1)

Publication Number Publication Date
DK1427728T3 true DK1427728T3 (da) 2007-07-09

Family

ID=23259997

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02799017T DK1427732T3 (da) 2001-09-20 2002-09-20 Spirocyclisk-6,7-dihydro-5H-pyrazolo[1,2-a] pyrazol-1-oner som kontrollerer inflammatoriske cytokiner
DK02763693T DK1427728T3 (da) 2001-09-20 2002-09-20 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02799017T DK1427732T3 (da) 2001-09-20 2002-09-20 Spirocyclisk-6,7-dihydro-5H-pyrazolo[1,2-a] pyrazol-1-oner som kontrollerer inflammatoriske cytokiner

Country Status (32)

Country Link
US (2) US6821971B2 (da)
EP (3) EP1427727B1 (da)
JP (3) JP2005504082A (da)
KR (4) KR20060036125A (da)
CN (3) CN1250551C (da)
AR (3) AR037502A1 (da)
AT (3) ATE332901T1 (da)
AU (2) AU2002327690B2 (da)
BR (3) BR0212716A (da)
CA (3) CA2461072A1 (da)
CO (3) CO5560589A2 (da)
CY (1) CY1106398T1 (da)
CZ (3) CZ2004345A3 (da)
DE (3) DE60202782T2 (da)
DK (2) DK1427732T3 (da)
EG (2) EG24413A (da)
ES (3) ES2282459T3 (da)
HU (3) HUP0402378A3 (da)
IL (3) IL160682A0 (da)
MA (3) MA27065A1 (da)
MX (3) MXPA04002569A (da)
MY (2) MY129329A (da)
NO (2) NO20041594L (da)
NZ (3) NZ531122A (da)
PE (3) PE20030446A1 (da)
PL (3) PL370415A1 (da)
PT (3) PT1427732E (da)
RU (3) RU2272040C2 (da)
SA (1) SA03230529B1 (da)
SK (3) SK1492004A3 (da)
WO (3) WO2003024973A1 (da)
ZA (3) ZA200401260B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849627B2 (en) 2001-09-20 2005-02-01 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7087615B2 (en) 2001-09-20 2006-08-08 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
US7473695B2 (en) * 2001-10-22 2009-01-06 Mitsubishi Tanabe Pharma Corporation 4-imidazolin-2-one compounds
US6677337B2 (en) * 2002-03-19 2004-01-13 The Procter & Gamble Company 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines
US6967254B2 (en) * 2002-09-09 2005-11-22 Amgen Inc. Substituted heterocyclic compounds and methods of use
US7557102B2 (en) * 2003-04-03 2009-07-07 Merck Patent Gmbh Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor Xa inhibitors for the treatment of thromboses
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7482356B2 (en) * 2003-11-10 2009-01-27 The Procter & Gamble Company Bicyclic pyrazolone cytokine inhibitors
BRPI0710507A2 (pt) * 2006-04-18 2011-08-16 Abbott Lab Antagonistas do receptor vanilóide de subtipo 1 (vr1) e usos destes
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
KR20120016247A (ko) * 2009-05-19 2012-02-23 다우 아그로사이언시즈 엘엘씨 진균 방제를 위한 화합물 및 방법
EP3308059B1 (en) 2015-06-15 2021-05-26 Cummins, Inc. Combustion chamber elasticity device
WO2017151409A1 (en) 2016-02-29 2017-09-08 University Of Florida Research Foundation, Incorporated Chemotherapeutic methods
CN107033090B (zh) * 2017-05-16 2019-05-07 无锡捷化医药科技有限公司 一种1,2,3,4-四氢噌啉的制备方法
RU2721684C1 (ru) * 2019-09-06 2020-05-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" Метил 2,3,8-триоксо-4-фенилтетрагидро-6Н-пиразоло[1,2-а]пирроло[2,3-c]пиразол-9а(1Н)-карбоксилаты
WO2023076133A1 (en) * 2021-10-27 2023-05-04 Merck Sharp & Dohme Llc Spirotricycle ripk1 inhibitors and methods of uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054291A (da) * 1963-02-26
GB1124982A (en) * 1965-02-09 1968-08-21 Lepetit Spa Diazabicyclo octanes and derivatives thereof
CH529154A (fr) 1969-10-27 1972-10-15 Lepetit Spa Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
KR100281450B1 (ko) * 1992-05-15 2001-02-01 슈테펜 엘. 네스비트 엔케팔리나제 및 안지오텐신 전환 효소의 억제제로서 유용한 신규 메르캅토아세틸아미도 피리다조[1,2]피리다진, 피라졸로[1,2]피리다진, 피리다조[1,2-a][1,2]디아제핀 및 피라졸로[1,2-a][1,2]디아제핀 유도체
GB9303993D0 (en) * 1993-02-26 1993-04-14 Fujisawa Pharmaceutical Co New heterocyclic derivatives
DK1481970T3 (da) * 1999-09-07 2006-07-31 Syngenta Participations Ag Nye herbicider
US6730668B2 (en) * 2001-09-20 2004-05-04 The Procter & Gamble Company 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines

Also Published As

Publication number Publication date
PT1427732E (pt) 2006-12-29
ES2268154T3 (es) 2007-03-16
IL160682A0 (en) 2004-08-31
EP1427728A1 (en) 2004-06-16
EP1427732A1 (en) 2004-06-16
NZ531123A (en) 2006-08-31
CA2461073A1 (en) 2003-03-27
PL370351A1 (en) 2005-05-16
CN1555375A (zh) 2004-12-15
CN1249066C (zh) 2006-04-05
BR0212673A (pt) 2004-08-24
NZ531122A (en) 2005-09-30
PL370415A1 (en) 2005-05-30
AU2002334641B2 (en) 2007-03-29
HUP0402378A3 (en) 2008-10-28
ZA200401403B (en) 2004-08-30
CZ2004345A3 (cs) 2004-06-16
PT1427727E (pt) 2005-06-30
EP1427727A1 (en) 2004-06-16
NO20041605L (no) 2004-06-21
ATE356126T1 (de) 2007-03-15
SK1492004A3 (en) 2004-11-03
KR20060036125A (ko) 2006-04-27
PE20030474A1 (es) 2003-07-22
ATE332901T1 (de) 2006-08-15
MY129329A (en) 2007-03-30
PL370362A1 (en) 2005-05-16
BR0212716A (pt) 2004-08-03
HK1071565A1 (en) 2005-07-22
MA27064A1 (fr) 2004-12-20
EG24363A (en) 2009-03-04
ZA200401260B (en) 2004-08-30
KR20040035835A (ko) 2004-04-29
AR037502A1 (es) 2004-11-17
CO5560590A2 (es) 2005-09-30
PT1427728E (pt) 2007-05-31
RU2004111806A (ru) 2005-03-27
RU2299885C2 (ru) 2007-05-27
JP2005504083A (ja) 2005-02-10
US6821971B2 (en) 2004-11-23
CN1257905C (zh) 2006-05-31
AR037237A1 (es) 2004-11-03
CO5560579A2 (es) 2005-09-30
EP1427732B1 (en) 2006-07-12
PE20030430A1 (es) 2003-06-24
DE60218704T2 (de) 2007-11-08
WO2003024973A1 (en) 2003-03-27
ZA200401402B (en) 2004-08-27
EP1427728B1 (en) 2007-03-07
DE60213108T2 (de) 2007-02-08
MXPA04002569A (es) 2004-05-31
KR100656126B1 (ko) 2006-12-12
CN1555379A (zh) 2004-12-15
AR037145A1 (es) 2004-10-27
HUP0402500A2 (hu) 2005-03-29
PE20030446A1 (es) 2003-07-21
NZ531063A (en) 2007-08-31
KR20040035836A (ko) 2004-04-29
CZ2004358A3 (cs) 2004-07-14
CN1556811A (zh) 2004-12-22
WO2003024971A1 (en) 2003-03-27
RU2004111803A (ru) 2005-10-10
JP2005504082A (ja) 2005-02-10
RU2004111805A (ru) 2005-04-10
CA2461072A1 (en) 2003-03-27
MY129069A (en) 2007-03-30
SK1502004A3 (en) 2004-09-08
KR100623879B1 (ko) 2006-09-19
DE60218704D1 (de) 2007-04-19
RU2272040C2 (ru) 2006-03-20
DE60202782D1 (de) 2005-03-03
MA27066A1 (fr) 2004-12-20
KR20040035837A (ko) 2004-04-29
DE60202782T2 (de) 2006-01-19
CY1106398T1 (el) 2011-10-12
ES2237691T3 (es) 2005-08-01
HUP0402500A3 (en) 2008-10-28
EP1427727B1 (en) 2005-01-26
CZ2004361A3 (cs) 2004-07-14
CA2461071A1 (en) 2003-03-27
DE60213108D1 (de) 2006-08-24
WO2003024970A1 (en) 2003-03-27
US20030105084A1 (en) 2003-06-05
EG24413A (en) 2009-05-25
RU2278864C2 (ru) 2006-06-27
US6566357B1 (en) 2003-05-20
HK1071366A1 (en) 2005-07-15
JP2005504081A (ja) 2005-02-10
NO20041594L (no) 2004-06-21
HUP0402378A2 (hu) 2005-02-28
CO5560589A2 (es) 2005-09-30
CN1250551C (zh) 2006-04-12
SA03230529B1 (ar) 2008-06-21
BR0212905A (pt) 2004-10-13
MXPA04002574A (es) 2004-06-18
DK1427732T3 (da) 2006-10-30
SK1482004A3 (en) 2004-08-03
ES2282459T3 (es) 2007-10-16
AU2002327690B2 (en) 2006-07-20
MA27065A1 (fr) 2004-12-20
IL160741A0 (en) 2004-08-31
HUP0500752A2 (en) 2006-01-30
IL160742A0 (en) 2004-08-31
MXPA04002570A (es) 2004-05-31
ATE287887T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
CY20162200002T2 (el) Αντιιικοι παραγοντες
DK1427728T3 (da) 6,7 -dihydro-5H-pyrazolo[1,2a]pyrazol-1-oner, som kontrollerer inflammatoriske cytokiner
AU2002351525A1 (en) System-on-a-chip controller
NO20042474L (no) Reguleringsventil-stromningsjusteringsanordning.
DK1399355T3 (da) Styringsenhed
BR0201807B1 (pt) controlador hidráulico.
FI20010885L (fi) Menetelmä rullaimen ohjaamiseksi
FI20012004A0 (fi) Kaapelointimenetelmä
NO20033189L (no) Kontrollmidler
DE60134712D1 (de) Regulierventil
AUPR795101A0 (en) Central shutter controller
DE50209593D1 (de) Antriebsregelung
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
AU2002327093A1 (en) 1,2-dihydro-2-oxo-1,8-naphthyridine derivative
FI5315U1 (fi) Sähköverkkoa hyväksikäyttävä valvontapuhelinjärjestelmä
AU2002240563A1 (en) Flow controller
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
FI20010181L (fi) Virtausohjain
DE50205113D1 (de) Regelventil
DK200100112U3 (da) Håndbetjening
FI20012524A0 (fi) Ohjausventtiili
AUPR513501A0 (en) Controller
AU2002244929A1 (en) Controller
HK1036705A (en) Power controlling network element
ITMI20011661A0 (it) Gruppo verniciatura